Comment: Win for doctors, insurance, and drug companies (Score 2) 392
But mostly a lose for patients.
The reason it's a win for doctors is that in our "fee for service" system they don't make much on a simple office visit, especially if they have to take the time to write a prescription. There's also ongoing overhead for prescriptions - whenever you run out of refills the pharmacy has to reauth, which takes up staff time. (This last is why the office where my son works has additional staff on hand on fridays, which is the day that everyone does their refills.) It may also reduce liability, although exactly how that will play out is harder to predict.
It's an obvious win for insurance because most OTC stuff isn't covered. And likewise for drug companies, who will sell more product, a lot of it to people who don't really need it.
The big losers will be patients. Sure, some people will have easier access to the meds they need. But costs will overall be higher, and some of the meds they are talking about aren't all that safe. Statins, for example, may be great at treating high cholesterol, but over time they can cause liver damage. Most of the antihypertensives are reasonably safe when taken at the correct dose, but take a bit too much and things like positional vertigo can occur. And as others have pointed out, the inability to track OTC meds can result in serious drug interactions or overdoses. Indeed, this is already a serious problem with acetaminenophen - so many different products contain it that it's easy to get an overdose, and boom goes your liver.
The reason it's a win for doctors is that in our "fee for service" system they don't make much on a simple office visit, especially if they have to take the time to write a prescription. There's also ongoing overhead for prescriptions - whenever you run out of refills the pharmacy has to reauth, which takes up staff time. (This last is why the office where my son works has additional staff on hand on fridays, which is the day that everyone does their refills.) It may also reduce liability, although exactly how that will play out is harder to predict.
It's an obvious win for insurance because most OTC stuff isn't covered. And likewise for drug companies, who will sell more product, a lot of it to people who don't really need it.
The big losers will be patients. Sure, some people will have easier access to the meds they need. But costs will overall be higher, and some of the meds they are talking about aren't all that safe. Statins, for example, may be great at treating high cholesterol, but over time they can cause liver damage. Most of the antihypertensives are reasonably safe when taken at the correct dose, but take a bit too much and things like positional vertigo can occur. And as others have pointed out, the inability to track OTC meds can result in serious drug interactions or overdoses. Indeed, this is already a serious problem with acetaminenophen - so many different products contain it that it's easy to get an overdose, and boom goes your liver.